Postpartum ASA and NT-proBNP

PHASE4CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

July 1, 2023

Primary Completion Date

May 21, 2024

Study Completion Date

May 21, 2024

Conditions
Blood Pressure
Interventions
DRUG

Aspirin 81Mg Ec Tab

Participant may be provided with a 6-week supply of 81 mg of aspirin prior to discharge from the delivery admission.

DRUG

Placebo

Participant may be provided with a 6-week supply of placebo to discharge from the delivery admission.

Trial Locations (1)

27705

Duke University, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT05889468 - Postpartum ASA and NT-proBNP | Biotech Hunter | Biotech Hunter